HYPOIMMUNOGENIC RHD NEGATIVE PRIMARY T CELLS Application WO-2022246293-A1 World Intellectual Property Organisation (WIPO) 24 Nov 2022
HUMANIZED ANTIBODY SPECIFIC FOR CD22 AND CHIMERIC ANTIGEN RECEPTOR USING THE SAME Application WO-2022145739-A1 World Intellectual Property Organisation (WIPO) 07 Jul 2022
FULLY HUMANIZED BISPECIFIC CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD22 AND USE… Application WO-2022002154-A1 World Intellectual Property Organisation (WIPO) 06 Jan 2022